Allen C. Clermont
Joslin Diabetes Center(US)University of Georgia(US)Augusta University(US)Jackson Memorial Hospital(US)Augusta University Health(US)KalVista Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Retinal Diseases and Treatments, Coagulation, Bradykinin, Polyphosphates, and Angioedema, Glaucoma and retinal disorders, Retinal Imaging and Analysis, Blood Coagulation and Thrombosis Mechanisms
Most-Cited Works
- → Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor(1996)1,103 cited
- → Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition(1999)786 cited
- → Vascular Endothelial Growth Factor–Induced Retinal Permeability Is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform–Selective Inhibitor(1997)669 cited
- → Activation of PKC-δ and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy(2009)420 cited
- → Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation(2007)353 cited
- → Decreased Cardiac Expression of Vascular Endothelial Growth Factor and Its Receptors in Insulin-Resistant and Diabetic States(2002)337 cited